Singapore markets open in 6 hours 35 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,302.34 +55.66 (+1.06%) Dow
39,835.00 +276.89 (+0.70%) Nasdaq
16,733.14 +221.96 (+1.34%) Bitcoin USD
65,308.14 +3,952.20 (+6.44%) CMC Crypto 200
1,373.31 +105.36 (+8.31%)
DYN May 2024 22.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:22AM EDT. Market open.
| Previous close | 4.4000 |
| Open | 3.9000 |
| Bid | 6.4000 |
| Ask | 9.5000 |
| Strike | 22.50 |
| Expiry date | 2024-05-17 |
| Day's range | 3.9000 - 4.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Simply Wall St.We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
Overview of Financial Performance and Future Prospects
GlobeNewswireDyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Additional Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Anticipated in the Second Half of 2024 - WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the first quarter of 2024 and recent business highlights. “I am excited about
© 2024 Yahoo. All rights reserved.